Jeil Pharma Holdings Inc (KRX:002620)
South Korea · Delayed Price · Currency is KRW 8,800.00
-90.00 (-1.01%)
At close: Sep 8, 2025
Jeil Pharma Holdings Market Cap
Jeil Pharma Holdings has a market cap or net worth of 135.09 billion as of September 8, 2025. Its market cap has decreased by -3.83% in one year.
Market Cap
135.09B
Enterprise Value
369.23B
Revenue
735.79B
Ranking
n/a
PE Ratio
n/a
Stock Price
8,800.00
Market Cap Chart
Since August 30, 1995, Jeil Pharma Holdings's market cap has increased from 26.30B to 135.09B, an increase of 413.73%. That is a compound annual growth rate of 5.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2025 | 135.09B | 12.53% |
| Dec 30, 2024 | 120.05B | -33.56% |
| Dec 28, 2023 | 180.68B | -23.57% |
| Dec 29, 2022 | 236.41B | -3.75% |
| Dec 30, 2021 | 245.62B | -24.53% |
| Dec 30, 2020 | 325.44B | 24.71% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 73.38T |
| Celltrion | 37.45T |
| ALTEOGEN | 25.54T |
| Yuhan | 9,104.15B |
| SK Biopharmaceuticals | 8,575.30B |
| PharmaResearch | 7,013.01B |
| Peptron | 6,756.23B |
| LigaChem Biosciences | 5,523.68B |